Haemodynamic and Tolerance Studies in Man of a New, Orally Active, Selective Beta1-adrenoceptor Agonist H 80/62

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1978 May 31

PMID 27371

Citations 20

Authors

G Johnsson

L Jordo

P Lundborg

O Ronn

J Wikstrand

Affiliations

Soon will be listed here.

Citing Articles

The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.

Muir A, Hannan W, Dewhurst N, SLESSOR I Br J Clin Pharmacol. 1981; 12(4):475-80.

PMID: 7295483 PMC: 1401886. DOI: 10.1111/j.1365-2125.1981.tb01253.x.

Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.

Drexler H, Lollgen H, Just H Klin Wochenschr. 1981; 59(12):647-54.

PMID: 7253539 DOI: 10.1007/BF02593856.

Pharmacokinetics of prenalterol after single and multiple administration of controlled release tablets to patients with congestive heart failure.

Dahlstrom U, Graffner C, Jonsson U, Hoffmann K, Karlsson E, Lagerstrom P Eur J Clin Pharmacol. 1983; 24(4):495-502.

PMID: 6861864 DOI: 10.1007/BF00609892.

Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure.

Sharpe D, Coxon R Eur J Clin Pharmacol. 1983; 25(4):539-45.

PMID: 6653650 DOI: 10.1007/BF00542125.

Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.

Pedersen T, Brynjolf I, Ording H, Nielsen P, Rasmussen K Eur J Clin Pharmacol. 1983; 25(3):287-92.

PMID: 6628515 DOI: 10.1007/BF01037935.

References

Brittain R, Jack D, Ritchie A . Recent beta-adrenoreceptor stimulants. Adv Drug Res. 1970; 5:197-253. View

Johnsson G . Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work. Acta Pharmacol Toxicol (Copenh). 1975; 36(Suppl 5):59-68. DOI: 10.1111/j.1600-0773.1975.tb03322.x. View

Carlsson E, Dahlof C, Hedberg A, Persson H, Tangstrand B . Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol. 1977; 300(2):101-5. DOI: 10.1007/BF00505039. View

WEISSLER A, KAMEN A, BORNSTEIN R, SCHOENFELD C, Cohen S . THE EFFECT OF DESLANOSIDE ON THE DURATION OF THE PHASES OF VENTRICULAR SYSTOLE IN MAN. Am J Cardiol. 1965; 15:153-61. DOI: 10.1016/0002-9149(65)90449-2. View

Ahmed S, LEVINSON G, Schwartz C, Ettinger P . Systolic time intervals as measures of the contractile state of the left ventricular myocardium in man. Circulation. 1972; 46(3):559-71. DOI: 10.1161/01.cir.46.3.559. View

Farmer J, Levy G, Marshall R . A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline. J Pharm Pharmacol. 1970; 22(12):945-7. DOI: 10.1111/j.2042-7158.1970.tb08481.x. View

Tuttle R, Mills J . Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975; 36(1):185-96. DOI: 10.1161/01.res.36.1.185. View

Wikstrand J, Nilsson K, WALLENTIN I . Distortion of non-invasive cardiac pulse curves. A capillary-damped pick-up and a calibration unit forapex cardiograms and other pulse curves. Br Heart J. 1977; 39(9):995-1005. PMC: 483359. DOI: 10.1136/hrt.39.9.995. View

Robie N, NUTTER D, Moody C, MCNAY J . In vivo analysis of adrenergic receptor activity of dobutamine. Circ Res. 1974; 34(5):663-71. DOI: 10.1161/01.res.34.5.663. View

10.

WEISSLER A, Harris W, SCHOENFELD C . Bedside technics for the evaluation of ventricular function in man. Am J Cardiol. 1969; 23(4):577-83. DOI: 10.1016/0002-9149(69)90012-5. View

11.

Knaus M, Pfister B, Dubach U, Imhof P . Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors. Am Heart J. 1978; 95(5):602-10. DOI: 10.1016/0002-8703(78)90302-2. View

12.

Brodsky M, Wu D, Denes P, Kanakis C, Rosen K . Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol. 1977; 39(3):390-5. DOI: 10.1016/s0002-9149(77)80094-5. View

13.

Johansson R, Regardh C, Sjogren J . Absorption of alprenolol in man from tablets with different rates of release. Acta Pharm Suec. 1971; 8(1):59-70. View